By analyzing #CD8+, CD4+, NKT, and γδ T cells, this study underscores the promise of TCR‑T, #CART, and checkpoint inhibitors in achieving long‑term AML control and advancing future therapeutic strategies. #medsky
To read: doi.org/10.1007/s115...

By analyzing #CD8+, CD4+, NKT, and γδ T cells, this study underscores the promise of TCR‑T, #CART, and checkpoint inhibitors in achieving long‑term AML control and advancing future therapeutic strategies. #medsky
To read: doi.org/10.1007/s115...
Breast Cancer Congress 2027
Join researchers, healthcare professionals, and experts for two days of knowledge sharing and collaboration.
June 17–18, 2027
Zurich, Switzerland
pinkribboncongress.com/registrations/
#BreastCancer #CancerResearch #Oncology #Healthcare #MedicalConferenc #BCC2027
Stuck on a patient question in clinic with no one around to ask? Specialist AI agents take your de-identified case and report back from each point of view. Free with OncoPulse.
🎨 New Post: Hope for Pancreatic Cancer: New Drug Darzanbrasib Offers Extended Survival
#ai #genomics #oncology #TechNews #GlobalMedia
👇 View Full Illustration:
https://nextlogic-ai.achlabo.com/en/hope-for-pancreatic-cancer-new-drug-darzanbrasib-offers-extended-survival/
#Ovarian & #Gynecologic cancers affect 100K+ US women every year but remain among the most under-researched & underfunded in #oncology. This #GynecologicCancerAwarenessMonth, we stand with the community to demand better outcomes.
#OncSky
An early-stage trial found encouraging outcomes with motixafortide, cemiplimab, gemcitabine, and nab-paclitaxel in newly diagnosed pancreatic cancer that had spread. @kenolivelab.bsky.social @columbiacancer.bsky.social #pancsm #oncology
Full story ➡️: www.onclive.com/view/a-new-c...
WATCH 👀: Brad S. Kahl, MD, of @washumedicine.bsky.social discusses EA4181 findings, whether cytarabine is needed with BTK inhibition, and the future of chemotherapy-free care in mantle cell lymphoma.
Full video ➡️: www.onclive.com/view/dr-kahl...
Is it too late to quit smoking after a cancer diagnosis?
No!
New IARC evidence shows better survival, less progression, and benefits even in advanced cancer.
Smoking cessation should be part of cancer care.
GRAIL’s Galleri multi-cancer blood test heads to an FDA advisory panel after the release of agency briefing materials.
#Biotechnology #Oncology #Biotech
Disclaimer: This is NOT a financial advice.
Cancer survivors face a critical gap: oncology's toxicity monitoring systems detect acute effects during treatment but miss serious long-term harms emerging years later. … #Adverseeffects #Cancer #Healthsystems #Lateeffects #Oncology #Adverseeffects #Cancer #Healthsystems #Lateeffects #Oncology…
📢 Get ready for #ENASymp26 Late-Breaking Abstract submissions!
Submit your latest data 12–19 October 2026.
📍 Barcelona 18–20 November
👉 Register: https://event.eortc.org/ena2026/registration/
American Association for Cancer Research (AACR) The National Cancer Institute
#CancerResearch #Oncology
Как ИИ спас пациента от неверного диагноза? Вместо обычного поиска, агентский подход выявил мутацию IDH1 в биопсии. Это превратило фатальный прогноз глиобластомы в управляемую стадию астроцитомы. #AI #Medicine #Oncology #LLM #HealthTech https://ai.dappcrypto.org/r/fA
How an agentic AI workflow corrected a fatal misdiagnosis. By prioritizing clinical guidelines over generic web search, we identified a hidden IDH1 mutation—turning certain death into long-term stability. #HealthAI #MedTech #Oncology #PrecisionMedicine #LLM https://ai.dappcrypto.org/r/fA
WATCH 📺: In this episode of #OncLiveOnAir 🎙️, Narjust Florez, MD, of @danafarber.bsky.social, and Jonathan Wesley Riess, MD, MS, of @ucdavis.bsky.social, discuss HER2 overexpression vs HER2 mutations in NSCLC. #lcsm #oncology
Watch or listen ➡️: www.onclive.com/view/recent-...
NHS launches pilot of rapid genomic test to cut brain tumour diagnosis from weeks to days
#nhs #genomics #brain-tumour #diagnostics #oncology
#TherapeuticPotential of combining #IRE1α and #KRAS inhibition in #PancreaticDuctalAdenocarcinoma doi.org/10.1073/pnas... #PDAC #Hypoxia #Oncology #LiverCancer #SolidTumor #TranslationalScience
Jim Koeller, the School's Alum of the Year, spent a decade working to establish #oncology #pharmacy with the Board of Pharmaceutical Specialties.
After they succeeded, he helped develop the specialty’s first examination for certification. Learn more: https://bit.ly/4d0P5l1
🔬 @mayoclinic.org researchers have identified a strategy that could help CAR-T cell therapy overcome a major barrier to treating solid tumors. #hncsm #oncology
Read more ➡️: www.onclive.com/view/study-s...